Kazia Therapeutics KZIA
NASDAQ KZIA
$7.81 -0.26 (-3.22%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Price to Earnings (2012 - 2013)

Updated

Kazia Therapeutics' Price to Earnings came in at 733.27 for the year ended Dec 31, 2012.

Analysis

Kazia Therapeutics (KZIA) Price to Earnings (2012 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Kazia Therapeutics 351,450.00 -52.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 3.72
Aug 30, 2013 1.14
Dec 31, 2012 0.90
API Access

Kazia Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=KZIA&period=max&api_key=YOUR_API_KEY